Collegium Pharmaceutical (COLL) Leases: 2019-2025
Historic Leases for Collegium Pharmaceutical (COLL) over the last 7 years, with Sep 2025 value amounting to $4.4 million.
- Collegium Pharmaceutical's Leases fell 28.16% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 28.16%. This contributed to the annual value of $5.8 million for FY2024, which is 3.43% down from last year.
- Per Collegium Pharmaceutical's latest filing, its Leases stood at $4.4 million for Q3 2025, which was down 15.79% from $5.3 million recorded in Q2 2025.
- In the past 5 years, Collegium Pharmaceutical's Leases registered a high of $8.2 million during Q1 2021, and its lowest value of $4.4 million during Q3 2025.
- Over the past 3 years, Collegium Pharmaceutical's median Leases value was $5.8 million (recorded in 2024), while the average stood at $5.8 million.
- Data for Collegium Pharmaceutical's Leases shows a maximum YoY decreased of 28.16% (in 2025) over the last 5 years.
- Quarterly analysis of 5 years shows Collegium Pharmaceutical's Leases stood at $7.6 million in 2021, then fell by 10.24% to $6.9 million in 2022, then fell by 12.13% to $6.0 million in 2023, then declined by 3.43% to $5.8 million in 2024, then declined by 28.16% to $4.4 million in 2025.
- Its Leases was $4.4 million in Q3 2025, compared to $5.3 million in Q2 2025 and $5.5 million in Q1 2025.